ArticleOncoimmunology2022

Coupling the immunomodulatory properties of the HDAC6 inhibitor ACY241 with Oxaliplatin promotes robust anti-tumor response in non-small cell lung cancer.

Arup Bag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.